A study comparing the early withdrawal of steroids to long-term maintenance steroid therapy in Kidney Transplant Patients receiving Prograf and Cellcept
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
397
Unnamed facility
Little Rock, Arkansas, United States
Assessment of death, graft loss, or severe acute rejection
Time frame: 6 months, 12 months, yearly up to 5 years
Comparison of patient and graf survival
Time frame: 6 months, 12 months, yearly up to 5 years
Incidence and severity of acute rejection
Time frame: 6 months, 12 months, yearly up to 5 years
Need for antilymphocyte treatment
Time frame: 6 months, 12 months, yearly up to 5 years
Graft function
Time frame: 6 month, 12 months, yearly up to 5 years
Framingham Coronary Heart Disease Risk Factors
Time frame: 6 months, 12 months, yearly up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Loma Linda, California, United States
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Denver, Colorado, United States
Unnamed facility
Chicago, Illinois, United States
Unnamed facility
Lexington, Kentucky, United States
Unnamed facility
New Orleans, Louisiana, United States
Unnamed facility
Baltimore, Maryland, United States
Unnamed facility
Boston, Massachusetts, United States
Unnamed facility
Detroit, Michigan, United States
...and 19 more locations